mHealth and HIV Self-testing

July 8, 2019 updated by: Don Operario, Brown University

mHealth and HIV Self-testing for High-risk Men in China

The investigators will pilot test an intervention to use a mobile application ("app") to improve HIV self-testing (HST) with high-risk men in China. Sixty participants will be randomly assigned to an intervention group - which involves access to a mobile app-based HIV testing health promotion and risk reduction program - versus control. Participants will be evaluated at baseline and at 6-month follow up with respect to HST and changes in sexual risk behaviors.

Study Overview

Detailed Description

Men who have sex with men (MSM) have emerged as one of the fastest growing HIV risk populations in China, the world's most populous country. Studies in China report that MSM have low rates of HIV testing, low use of HIV prevention services, and high levels of unprotected sex with both male and female partners. Stigma presents one of the critical barriers to engaging MSM in HIV testing and prevention interventions, as many MSM in China avoid health service facilities that require face-to-face disclosure of their same-sex behaviors. Because HIV testing is a crucial opportunity for HIV prevention and represents the first step on the continuum of care, efforts to improve rates of HIV testing among MSM in China can contribute to reduced risk for HIV transmission and enhanced public health outcomes in this population.

For high-risk MSM in China, HIV self-testing (HST) offers a compelling strategy for achieving higher levels of HIV testing, due to the removal of barriers associated with traditional forms of in-person, clinic-based HIV testing. HST allows individuals to self-administer the HIV rapid diagnostic test in a private setting, which can detect for the presence of HIV-1/2 antibodies. The overarching goal of this research investigation is to improve the implementation science of HIV self-testing (HST) as a public health strategy to increase HIV testing among populations with low testing rates.

The investigators propose using a mHealth approach to support the implementation of HST. Specifically, the investigators hypothesize that incorporating mobile application- or "app"-based behavioral risk reduction messages with HST can preserve the privacy and comfort associated with self-administered testing, while also allowing for individuals to receive timely information and motivational cues to take the crucial next steps following their HST results - i.e., to test repeatedly, to reduce their behavioral risks for HIV transmission, and to seek appropriate referral services as needed.

This research will examine the acceptability and preliminary effects of HST linked with app-based behavioral risk reduction messages in a sample of high-risk MSM in China. In this pilot study, the investigators will test the primary hypothesis that the combination of HST plus mobile app-based risk reduction messaging compared to HST alone will increase HST re-testing and reduce sexual risk behavior in the next 6 months.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Anhui
      • Hefei, Anhui, China
        • Anhui Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Age 18 or older
  • Biological male
  • Unprotected anal sex during the past 6 months
  • Current resident in Hefei (city), China
  • HIV-negative or HIV-status unknown
  • Possess a mobile "smart" phone
  • Not planning to relocate from study location

Exclusion Criteria:

  • HIV positive at enrollment
  • Self-report coercion to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobile "WeChat" intervention
Participants will watch a demonstration of HIV self-testing, receive HIV self-testing kits, and receive access to a mobile health application that delivers content to promote HIV-self testing and reduce HIV-related risk behavior.
Participants watch a demonstration of HIV self-testing, receive HIV self-testing kits, and receive access to a mobile application that delivers content to promote HIV self-testing and reduce HIV risk behavior
Active Comparator: Control condition
Participants will watch a demonstration of HIV self-testing and receive HIV self-testing kits.
Participants watch a demonstration of HIV self-testing and receive HIV self-testing kits.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HIV self-testing, picture
Time Frame: 6 months
Picture of HIV self-test result submitted via mobile app
6 months
HIV self-testing, self-reported
Time Frame: 6 months
Self-reported use of HIV self-test kit
6 months
HIV risk behavior
Time Frame: 6 months
Condomless sex acts
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Don Operario, PhD, Brown University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Actual)

June 30, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

June 15, 2018

First Submitted That Met QC Criteria

June 15, 2018

First Posted (Actual)

June 26, 2018

Study Record Updates

Last Update Posted (Actual)

July 9, 2019

Last Update Submitted That Met QC Criteria

July 8, 2019

Last Verified

June 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • R34MH106349 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobile Health Intervention to Promote HIV Self-testing

  • Case Western Reserve University
    National Human Genome Research Institute (NHGRI)
    Not yet recruiting
    Pregnancy | Health Education | Self Efficacy | Decision Making | Informed Consent | Delivery of Health Care | Internet-Based Intervention | Genetic Testing | Humans | Noninvasive Prenatal Testing | Pregnant People | Patient Education as Topic/Method
    United States
  • European Foundation for the Care of Newborn Infants
    Not yet recruiting
    Self-Assessment | Development of a Tool to Assess the Level of Implementing the European Standards of Care for Newborn Health | Testing of the Developed Self-assessment Tool in European Hospitals
    Germany
  • Fred Hutchinson Cancer Center
    National Institute of Mental Health (NIMH); Asociación Civil Via Libre, Peru; Epicentro, Peru
    Active, not recruiting
    HIV/AIDS | HIV Prevention | Feasibility Studies | HIV Testing | Implementation Science | Social Determinants of Health | Mobile Health | Health Services Accessibility | Linkage to Care | Qualitative Research | Global Health
    Peru

Clinical Trials on Mobile "WeChat" intervention

Subscribe